Common Contracts
3 similar Underwriting Agreement contracts by Avago Technologies LTD, Jazz Pharmaceuticals PLC
AVAGO TECHNOLOGIES LIMITED Ordinary Shares UNDERWRITING AGREEMENTUnderwriting Agreement • December 10th, 2012 • Avago Technologies LTD • Semiconductors & related devices • New York
Certain shareholders of Avago Technologies Limited, a company organized under the laws of the Republic of Singapore (the “Company”), named in Schedule 2 attached hereto (the “Selling Shareholders”), propose to sell an aggregate of 21,490,022 (the “Shares”) of the Company’s Ordinary Shares, no par value per share (the “Ordinary Shares”). This is to confirm the agreement concerning the purchase of the Shares from the Selling Shareholders by the underwriter (the “Underwriter”) named in Schedule 1 attached to this agreement (this “Agreement”).
JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY Ordinary Shares UNDERWRITING AGREEMENTUnderwriting Agreement • March 7th, 2012 • Jazz Pharmaceuticals PLC • Pharmaceutical preparations • New York
The certain shareholders of Jazz Pharmaceuticals Public Limited Company, a public limited company incorporated in Ireland (the “Company”) named in Schedule 2 (the “Selling Shareholders”) attached to this Agreement (this “Agreement”) propose to sell an aggregate of 7,883,366 shares (the “Shares”) of the Company’s ordinary shares, nominal value $0.0001 per share (the “Ordinary Shares”) to each of the underwriters named in Schedule 1 attached hereto (the “Underwriters”), for whom Barclays Capital Inc. and Citigroup Global Markets Inc. are acting as Representatives (the “Representatives”). This Agreement is to confirm the agreement concerning the purchase of the Shares from the Selling Shareholders by the Underwriters.
AVAGO TECHNOLOGIES LIMITED Ordinary Shares UNDERWRITING AGREEMENTUnderwriting Agreement • August 13th, 2010 • Avago Technologies LTD • Semiconductors & related devices • New York
Certain shareholders of Avago Technologies Limited, a company organized under the laws of the Republic of Singapore (the “Company”), named in Schedule 2 attached hereto (the “Selling Shareholders”), propose to sell an aggregate of 14,905,000 shares (the “Firm Shares”) of the Company’s Ordinary Shares, no par value per share (the “Ordinary Shares”). In addition, the Selling Shareholders propose to grant to the underwriters (the “Underwriters”) named in Schedule 1 attached to this agreement (this “Agreement”) an option to purchase up to an aggregate of 2,235,750 additional shares of the Ordinary Shares on the terms set forth in Section 3 (the “Option Shares”). The Firm Shares and the Option Shares, if purchased, are hereinafter collectively called the “Shares.” This is to confirm the agreement concerning the purchase of the Shares from the Selling Shareholders by the Underwriters.
